CN101974089B - Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection - Google Patents

Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection Download PDF

Info

Publication number
CN101974089B
CN101974089B CN2010101977294A CN201010197729A CN101974089B CN 101974089 B CN101974089 B CN 101974089B CN 2010101977294 A CN2010101977294 A CN 2010101977294A CN 201010197729 A CN201010197729 A CN 201010197729A CN 101974089 B CN101974089 B CN 101974089B
Authority
CN
China
Prior art keywords
tat
hmsra
trx
protein
fusion rotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010101977294A
Other languages
Chinese (zh)
Other versions
CN101974089A (en
Inventor
陈建国
曾建华
吴鹏飞
王芳
张醉
杨远坚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huazhong University of Science and Technology
Original Assignee
Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huazhong University of Science and Technology filed Critical Huazhong University of Science and Technology
Priority to CN2010101977294A priority Critical patent/CN101974089B/en
Publication of CN101974089A publication Critical patent/CN101974089A/en
Application granted granted Critical
Publication of CN101974089B publication Critical patent/CN101974089B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

The invention discloses a preparation method of a fusion protein Trx-TAT-hMsrA and application thereof to an aspect of nerve cell protection. The fusion protein Trx-TAT-hMsrA comprises a TAT protein transduction structure domain, thioredoxin Trx and anthropogenic methionine sulfoxide reductase hMsrA. The fusion protein of the invention has various biological effects for reducing the oxidization of functional protein methionine residues, treating oxidative stress injury, relieving the relevant nerve cell pathological change of parkinsonism, preventing and treating calcium ion overloading and the like, simultaneously has good capability for entering nerve cells through the epicyte, and belongs to novel biotechnological medicine candidates with good druggability.

Description

Reorganization Trx-TAT-hMsrA fusion rotein and the application aspect neurocyte protection thereof
Technical field
The invention belongs to gene engineering technology field; Being specifically related to a kind of fusion has TAT nexin transduction domain and humanized's methionine sulphoxide reductase enzyme hMsrA and the formed fusion rotein of sulphur hydrogen reduction albumen Trx (reorganization Trx-TAT-hMsrA fusion rotein), and preparation method thereof and the application aspect neurocyte protection.
Background technology
A large amount of modern Neuroscience Research show that the pathology damage of Mediated by Free Radicals is participated in the generation and the development of multiple neural system major disease.The abundant lipid content of brain makes it easier impaired in oxidative stress with the antioxidase level that lacks relatively.Multiple factor (as unusual folded protein gather, ischemical reperfusion injury etc.) induce neurone to produce more active oxygen (ROS) through approach such as plastosome aerobic repiration, like O 2-., H 2O 2, OH and 1O 2, and in the aging course often with the weakening of ROS scavenge system (like gsh restoring system, superoxide-dismutase etc.), thereby cause the abnormal accumulation of oxyradical or oxidation products, cause the generation of neural system major disease.Protein is the basic substance of most cells physiological activity; Oxyradical is for the oxidative modification of functional protein such as ionic channel, enzyme and acceptor etc.; Tend to cause the inactivation of protein function, unusual even proteinic degraded aggravation, thus the disorder of mediated cell physiological function.What be vulnerable to attack most in the protein molecule is the sulfur-containing amino acid residue; Comprise cysteine residues (cysteine, Cys) and methionine(Met) (methionine, Met) residue; The oxidation products of Cys comprises sulfeno disulphide and sulfo group, is main with disulphide usually.When having reducing substanceses such as sulphur hydrogen reduction albumen or the external DTT of existence in the body, disulfide linkage is prone to be reduced into sulfydryl.The cysteine residues oxidation forms disulfide linkage; Can influence comprise the important proteic functions of neural system such as L type calcium channel, glutamate receptor; The applicant belongs to breadboard big quantity research and shows; Use sulfydryl reductibility medicine to reverse this variation of reduction, can treat old and feeble relevant cynapse function damage.The methionine residue oxidation is another crucial induction factor of protein function oxidative damage.Under the weak oxidant effect, methionine(Met) is prone to be oxidized to MetO, under the effect of more strong oxidizer such as Ch-T, can further be oxidized to MetO2.MetO can be reduced into Met by the methionine(Met) reductase enzyme, but MetO2 is highly stable, can not be reduced under the physiological condition.See that from structure normal methionine(Met) side chain is very long, flexible, nonpolarity.After being oxidized to MetO, it is stiff that side chain becomes, and it is big that polarity becomes, thereby whole protein function is changed.External a large amount of breadboard researchs show, the methionine residue oxidation of key protein matter is closely related with the incidence and development of multiple neural system major disease.The applicant belongs to breadboard big quantity research and shows, the oxidative modification of protein methionine residue and ion channel function are unusual, synaptic plasticity damage and cell calcium stable state are unbalance all has substantial connection.Therefore, regulate the oxidation of protein methionine residue, possibly become the New Policy of treatment neural system major disease.
(methionine sulfoxide reductase A is that can reducing in vivo of finding at present reverses that protein methionine residue oxidation structure changes and the main antioxidase system of function damage MsrA) to methionine sulphoxide reductase enzyme A.MsrA is in a lot of organisms, and very ancient archeobacteria intestinal bacteria all have discovery to plant and Mammals on evolving, and its antioxygenation has the meaning of particularly important for the existence of organism.Big quantity research shows that MsrA is a kind of anti-oxidant reparative factor that is present in the organism.Cross and express the MsrA gene and can significantly alleviate human T-cell, people Lens cell, PC12 cell and isocellular damage of WI-38SV40 and the apoptosis that oxidative stress causes.There is research to think that MsrA and aging and Mammals life-span are closely related.Therefore, regulate the genetic expression of MsrA, new angle and technique means are provided for treating the relevant pathologic conditions of multiple oxidation.And sulphur hydrogen reduction albumen (Trx) be in a kind of lower molecular weight, the evolution high conservative reduction disulfide linkage oxidation products active protein arranged, major function is to regulate redox equilibriums in the cell born of the same parents, participates in oxidative stress inductive apoptosis.It is that the MsrA system brings into play the most important mate molecule of function in vivo, also is simultaneously to go back cysteine residues oxidation most important function molecule in the substance, and we imagine, and through the method for recombination, prepare the fusion rotein of a kind of MsrA and Trx.In the neural system major disease, numerous disease is closely related with oxidative damage and apoptosis, comprises parkinsonism, ischemic brain injury, senile dementia, vascular dementia etc.Use this fusion rotein, in these treatment of diseases, possibly play important effect.
Methionine sulphoxide reductase enzyme A (MsrA) and sulphur hydrogen reduction albumen (Trx) all are functional protein in essence, can prepare according to engineered method.But protein-based biotech drug is difficult to get into cell, the peripherally administered also very difficult hemato encephalic barrier that sees through.For these that overcome pharmaceutical grade protein become the shortcoming of property of medicine differences, development can be used in the new bio technical agent of central nervous system disease, and we imagine through MsrA and the Trx of recombination transformation as functional protein.HIV-1 virus is a kind of have very strong penetration cell and protein particulate that gets into the cns ability, and it gets into cell is its Tat albumen 49-57 amino acids with the key structure territory that gets into cns.This Tat dietary protein origin wear the little peptide in membrane structure territory, get in transporter matter and showing extremely strong application prospect aspect the cell.We pass through gene engineering method at imagination; The wear little peptide in membrane structure territory, humanized's methionine sulphoxide reductase enzyme A albumen and the sulphur hydrogen reduction albumen of Tat dietary protein origin are built into fusion rotein, thereby are used for preparation treatment neural system major disease related drugs in the future.
Summary of the invention
The purpose of this invention is to provide a kind of fusion rotein, make it have the neurocyte protection effect.
Another task of the present invention provides the preparation method and the application of this fusion rotein.
Realize that technical scheme of the present invention is:
This fusion rotein provided by the invention is made up of sulphur hydrogen reduction albumen Trx and TAT nexin transduction domain and humanized's methionine sulphoxide reductase enzyme hMsrA, and patented claim of the present invention is called reorganization Trx-TAT-hMsrA fusion rotein with this fusion rotein.
Reorganization Trx-TAT-hMsrA fusion rotein provided by the invention has 416 amino acid altogether, and wherein the 1-109 amino acids is a Trx albumen, and the 110-165 amino acids is the joining region, and the 166-179 amino acids is a TAT albumen, and the 180-416 amino acids is a hMsrA albumen.Reorganization Trx-TAT-hMsrA fusion rotein provided by the invention is just like the aminoacid sequence shown in the SEQ ID NO:1, and molecular weight is 45KD.
Reorganization Trx-TAT-hMsrA fusion rotein comprises three functional zone, and the function of each functional zone is following: the Trx major function is to regulate redox equilibrium in the cell born of the same parents; TAT albumen is a polypeptide fragment that is rich in basic aminoacids, and major function is a guiding reorganization Trx-Tat-hMsrA fusion rotein permeates cell membranes; Humanized's methionine sulphoxide reductase enzyme hMsrA is the unique reductase enzyme that can go back the oxidation of crude protein methionine residue in the body, and major function is to repair the damage of protein oxidation property.Because numerous disease is closely related with oxidative damage, comprise parkinsonism, ischemic brain injury, senile dementia, vascular dementia etc., the present invention's Trx-TAT-hMsrA fusion rotein of recombinating can be used for these treatment of diseases.
Experimental data one:
The preparation method that patented claim embodiment 1 of the present invention provides the present invention to recombinate the Trx-TAT-hMsrA fusion rotein.Experimental data one provides the present invention the Trx-TAT-hMsrA fusion rotein materials of identification of recombinating.
1. the Western blot of reorganization Trx-TAT-hMsrA fusion rotein identifies
Fusion rotein is Western blot and is detected test.Deposition condition and embodiment two are consistent.Press table three preparation transfering buffering liquid.Press table four preparation TBST damping fluid.After electrophoresis finishes, cut out the glue about target protein position (45KD) according to albumen market, immersing with NC film, filter paper changeed in the film liquid balance at least 15 minutes.According to negative pole, sponge, filter paper, glue, the NC film, filter paper, sponge, anodal puts it in proper order to be changeed in the bellows, and the wet commentaries on classics method of constant current is transferred to albumen on the NC film from glue.After changeing film and finishing, the NC film was immersed in the confining liquid in (5% degrease milk powder is dissolved in TBST) sealing 1 hour, with one anti-(1% degrease milk powder is dissolved in the TBST preparation) that the NC film places proper concn, 4 ℃ of vibration incubated overnight.After the abundant rinsing of TBST, add two of HRP mark and resist, after the abundant rinsing of .TBST in 1 hour is hatched in vibration under the room temperature, the ECL fluorescent agent, 5 minutes, according to fluorescence intensity, the correct exposure compressing tablet developed. after the film scanning, with the density of Image J software analysis development.
Table three
Table four
Figure GDA0000022229800000041
(Upstate USA) further confirms this fusion rotein Trx-TAT-hMsrA fusion rotein of recombinating exactly with MsrA antibody.Referring to accompanying drawing 4.
2. the film activity of wearing of reorganization Trx-TAT-hMsrA fusion rotein is identified
In the DMEM substratum, cultivate the Chinese hamster ovary celI strain, went down to posterity once in 2-3 days.When cell state is better, plant on slide.Use reorganization Trx-TAT-hMsrA fusion rotein (5nM) incubated cell, fixing after 24 hours.(Upstate USA) carries out the cellular immunofluorescence experiment to use MsrA antibody.Step comprises: preparation PBS solution 250ml:Na2HPO4:0.725g; NaH2PO4:0.075g; Nacl:2.25g.Regulate PH to 7.2-7.4.There is the slide of cell to put into 24 orifice plates with long, PBS rinsing three times, each 10min; Every hole adds 4% the Paraformaldehyde 96 of 500ul, and 20min carries out cell fixation; PBS rinsing three times, each 10min;
Every hole adds 0.3% the passing through of Triton of 500ul, 30min; 3% the BSA that every hole adds 500ul seals 30min; Use 1: 500 ratio, in the PBS that contains 1%BSA, 10%Triton and NGS (sheep blood serum) 3%, add MsrA antibody, 4 ℃, spend the night; PBS rinsing three times, each 10min; Use 1: 1000 ratio, in the PBS that contains 1%BSA, 10%Triton and NGS (sheep blood serum) 3%, add FITC mark mouse-anti rabbit two and resist room temperature, 2h; PBS rinsing three times, each 10min; 30% glycerine mounting, cell faces down.Use the Lycra fluorescent microscope to take pictures.The result shows that reorganization Trx-TAT-hMsrA fusion rotein can get into Chinese hamster ovary celI.Conclusion: reorganization Trx-TAT-hMsrA fusion rotein has film activity.See Fig. 5.
3. the methionine sulphoxide reducing activity of reorganization Trx-TAT-hMsrA fusion rotein is identified
The measuring method of methionine sulphoxide reductase activity is followed the method that this laboratory has been set up: preparation contains the reaction solution of following reaction reagent, and its final concentration is respectively: MgCl 210mM; KCl 30mM; Tris.HCl 25mM; WR 34678 1mM.Regulate PH to 7.4 with hydrochloric acid.The adding methionine sulphoxide is to final concentration 10mM and add sample to be tested to this reaction solution; 37 ℃ of reactions are after 60 minutes; Add colour developing liquid Ellman reagent (5; 5 '-dithio-two-2-nitrobenzoic acid) 0.01M and NaOH 0.1M regulate PH to 8.0-8.5, and 37 ℃ are reacted 5-10 minute with the ELIASA detection 412nm OD of place value.With the OD value after background liquid OD value that does not add reactant and the reaction end, bring following formula into, calculate enzyme and live:
Enzyme (U/ml)=(OD enzyme background-OD enzyme reaction) * V system alive * diluted sample multiple/reaction times * 1* ε TNB*V sample
In the formula:
The OD enzyme reaction finishes the OD value in afterreaction hole for reaction; OD enzyme background finishes the OD value in rear backdrop hole for reaction, and the V system is the reaction TV, and the V sample is that population of samples is long-pending; L is light path thickness (instrument(al)constant), ε TNB: be the optical extinction coefficient of sulfo--2-nitrobenzoic acid.L* ε TNB numerical value can also can calculate through typical curve through searching the instrument specification sheets and chemical handbook method obtains.The making method of typical curve: with damping fluid (MgCl 210mM, KCl 30mM, Tris.HCl 25mM; PH=7.4) configuration different concns WR 34678 (100 μ M-2000 μ M); Reacted 10 minutes at 37 ℃ with DTNB methanol solution (0.01M) equal-volume, add NaOH solution (0.1M) and regulate PH, read the OD value at the 412nm place to 8.0-8.5; OD value and WR 34678 concentration are carried out linear regression analysis, can calculate l* ε TNB numerical value.In 96 orifice plates, add damping fluid (MgCl 210mM, KCl 30mM, Tris.HCl 25mM, PH=7.4) each 50 μ l of the WR 34678 (1mM) of configuration and methionine sulphoxide solution (10mM) are as reacting hole; The WR 34678 of damping fluid configuration and each 50 μ l of damping fluid are the hole as a setting.37 ℃ of preheatings 10 minutes.The protein liquid that adds etc. protein content 5 μ g and 10 μ g to reacting hole and corresponding background hole respectively.37 ℃ of joltings were reacted 60 minutes.Add 20 μ l NaOH solution (0.1M) respectively to reacting hole and corresponding background hole.37 ℃ of joltings 5 minutes.Add 100 μ l reagent E llman reagent (0.01M) respectively to reacting hole and corresponding background hole.37 ℃ of joltings 5 minutes.With ELIASA at the 412nm place reading numerical values, by formula:
Enzyme (U/ml)=(OD enzyme background-OD enzyme reaction) * V system alive * diluted sample multiple/reaction times * l* ε TNB*V sample
Calculate enzymic activity.
Table five reaction system OD value and protease activity
Enzyme amount (μ g) OD background OD reaction enzymes (U/g) alive
5 0.498 0.355 326
10 0.942 0.634 544
Conclusion: the reorganization Trx-TAT-hMsrA fusion rotein of table five explanation preparation has the activity of reduction methionine sulphoxide.
Experimental data two: reorganization Trx-TAT-hMsrA fusion rotein is to the provide protection of neural cell injury
1, reorganization Trx-TAT-hMsrA fusion rotein causes the provide protection of neural cell injury for oxidative stress
The neural female tumor cell strain SH-SY5Y of humanized uses the DMEM culture medium culturing that contains 15% foetal calf serum in 37 degrees centigrade of 5%CO2 incubators.Went down to posterity once in every 3-5 days.The experiment before with the SH-SY5Y kind in 96 orifice plates.Use hydrogen peroxide 250 μ M to handle and made oxidative stress damaging cells model in 12 hours.Reorganization Trx-TAT-hMsrA fusion rotein (5nM and 0.5nM) adds in hydrogen peroxide and added substratum in preceding 2 hours, and remains to the experiment end always.Experiment finishes the back and uses MTT to detect cytoactive.Culture supernatant liquid in the hole is absorbed in each hole, adds the serum-free cell culture medium 200ul that contains 0.5mg/ml MTT and continues to hatch 4 hours, stops cultivating; Absorb culture supernatant liquid in the hole; Every hole adds 100 μ l DMSO, vibrates 10 minutes, carries out colorimetric immediately after crystallisate is fully melted; The mensuration wavelength is 570nm, and on ELIASA, measuring each hole absorbancy is the OD value.Detection hole OD value deducts blank well zeroing hole OD value and is the actual OD value in detection hole.The result is referring to accompanying drawing 6.The result shows that hydrogen peroxide 250 μ M handle and can cause that tangible cytoactive descended in 12 hours, and the processing of Trx-TAT-hMsrA fusion rotein can significantly improve the cytoactive after the hydrogen peroxide treatment.
2, reorganization Trx-TAT-hMsrA fusion rotein causes the provide protection of neural cell injury for parkinsonism related pathologies factor MPP
The neural female tumor cell strain SH-SY5Y of humanized uses the DMEM culture medium culturing that contains 15% foetal calf serum in 37 degrees centigrade of 5%CO2 incubators.Went down to posterity once in every 3-5 days.The experiment before with the SH-SY5Y kind in 96 orifice plates.Use MPP (sigma) 2mM to handle and made PD relevant cell damage model in 48 hours.Reorganization Trx-TAT-hMsrA fusion rotein (5nM and 0.5nM) adds in MPP and added substratum in preceding 2 hours, and remains to the experiment end always.Experiment finishes the back and uses MTT to detect cytoactive.Culture supernatant liquid in the hole is absorbed in each hole, adds the serum-free cell culture medium 200ul that contains 0.5mg/ml MTT and continues to hatch 4 hours, stops cultivating; Absorb culture supernatant liquid in the hole; Every hole adds 100 μ l DMSO, vibrates 10 minutes, carries out colorimetric immediately after crystallisate is fully melted; The mensuration wavelength is 570nm, and on ELIASA, measuring each hole absorbancy is the OD value.Detection hole OD value deducts blank well zeroing hole OD value and is the actual OD value in detection hole.The result is referring to accompanying drawing 7.The result shows that MPP (2mM) handles and can cause that tangible cytoactive descended in 24 hours, and the Trx-TAT-hMsrA fusion rotein is handled the cytoactive that can significantly improve after MPP handles.
3, reorganization Trx-TAT-hMsrA fusion rotein causes the provide protection of cell calcium overload for oxidation
In the DMEM substratum, cultivate the Chinese hamster ovary celI strain, went down to posterity once in 2-3 days.When cell state is better, plant on slide.Use reorganization Trx-TAT-hMsrA fusion rotein (5nM) incubated cell, carry out the calcium ion imaging experiment after 24 hours.Use Fura-2/AM probe incubated cell.Fura-2/AM is an Ester, can permeate through cell membranes, can be become activated Fura-2 by esterase hydrolyzed specific in the born of the same parents again, then with born of the same parents in Free Ca 2+In conjunction with, be respectively about 340nm and 380nm in conjunction with the excitation wavelength of after product.[Ca in the born of the same parents 2+] iCan be directly calculate promptly two excitation wavelength fluorescent methods by the ratio of the fluorescence intensity on two excitation wavelengths.With after being seeded in Chinese hamster ovary celI strain on the slide and cleaning three times with extracellular fluid, adding the certain volume final concentration is 1 μ M Fura-2/AM, hatches 30min for 37 ℃.Clean twice again and begin experiment to remove the outer Fura-2/AM of born of the same parents.Ca in the born of the same parents 2+Signal with fluorescence survey the calcium system detect (TILL Photpnics GmbH, Germany).The native system major parts comprises: OLYMPUS inverted microscope, CCD, optical fiber cold light source, unit and computingmachine Vision process software etc.Cell sheet glass is put into the cell groove that is fixed on inverted microscope (Olympus IX-70) moveable platform, and with normal extracellular fluid perfusion, perfusion rate is 1.5~4ml/min.Microscopically is observed, and the good cell of selection mode is as detected object.Corresponding cell is selected region of interest (ROI), as real-time monitored object.Fluorescence with 340nm and 380nm excites respectively.Per second writes down the F340/F380 fluorescence ratio image of a width of cloth ROIs.The F340/F380 fluorescence ratio is represented the concentration of intracellular calcium.Experimental data is carried out record by TILLVISION software, imports at last to carry out data analysis in the Excel form.The result is referring to accompanying drawing 8.The result shows, 2mM H 2O 2[the Ca of remarkable rising CHO 2+] i, but use the cell after reorganization Trx-TAT-hMsrA fusion rotein is handled, its [Ca 2+] iThe rising amplitude significantly is lower than contrast, and prompting reorganization Trx-TAT-hMsrA fusion rotein can reduce the calcium ion overload that oxidation causes.
The present invention is cleverly with TAT albumen transfer system and humanized's methionine sulphoxide reductase enzyme hMsrA and sulphur hydrogen reduction albumen Trx formation fusion rotein; Having overcome in the past, these macromolecular enzymes can not get into intracellular shortcoming; Their new functions have been given; Make them can stride across stopping of cytolemma, in cell, bring into play anti-oxidant function.The easiest oxidized cysteine residues (cysteine in the protein; Cys) and methionine(Met) (methionine; Met) residue can be reduced by sulphur hydrogen reduction albumen Trx and humanized's methionine sulphoxide reductase enzyme hMsrA respectively, thus the damage that opposing ROS oxyradical causes neurocyte.Experiment confirm of the present invention, fusion rotein provided by the invention has provide protection to neural cell injury, can be used for the medicine of preparation treatment neural system major disease (comprising parkinsonism, ischemic brain injury, senile dementia, vascular dementia etc.).
Description of drawings
Fig. 1: the structure of reorganization Trx-TAT-hMsrA fusion protein expression vector; Fig. 1 reflection be, the position that Tat-hMsrA inserts, between the BamHI and XhoI restriction enzyme site of expression vector pet32a, Trx albumen is in the front of Tat-hMsrA, between contain the his tag label that purifying is used.
Fig. 2: reorganization Trx-TAT-hMsrA fusion rotein SDS-PAGE coomassie brilliant blue staining result of supernatant behind the abduction delivering in BL21 (DE3) expression strain; Fig. 2 reflection be, reorganization Trx-TAT-hMsrA fusion rotein in BL21 (DE3) expression strain behind the abduction delivering, the result of supernatant SDS-PAGE coomassie brilliant blue staining.Among the figure, M represents protein molecular weight Marker; 1,3: added white protein on the bacterial strain of recombinant protein inductor IPTG; 2,4: do not add white protein on the bacterial strain of recombinant protein inductor IPTG.
Fig. 3: the SDS-PAGE coomassie brilliant blue staining result of reorganization Trx-TAT-hMsrA fusion rotein behind the purifying; What Fig. 3 reflected is the result of the recombinant protein SDS-PAGE coomassie brilliant blue staining before and after the purifying.Among the figure, M represents protein molecular weight Marker; 1: represent the preceding bacterial strain supernatant total protein of purifying; 2: representative strain supernatant total protein is through the product behind purifying; 3: representative strain supernatant total protein is through the product behind twice purifying; 4: representative strain supernatant total protein is through the product behind three purifying.
Fig. 4: the Western Blotting result of reorganization Trx-TAT-hMsrA fusion rotein behind the purifying; What Fig. 4 reflected is the result that the recombinant protein Western Blotting behind the purifying detects.Among the figure, 1: represent the positive control cerebral tissue to extract the expression of MsrA in the albumen; 2: the MsrA antigenicity of representing recombinant protein behind the purifying.
Fig. 5: reorganization Trx-TAT-hMsrA fusion rotein wears the film activity qualification result behind the purifying; What Fig. 5 reflected is that the recombinant protein behind the purifying sees through the ability of Chinese hamster ovary celI.Among the figure, 1: the Chinese hamster ovary celI that representative is handled without recombinant protein; 2: the Chinese hamster ovary celI that representative is handled through recombinant protein.
Fig. 6: reorganization Trx-TAT-hMsrA fusion rotein is for the provide protection of oxidative stress neural cell injury behind the purifying; What Fig. 6 reflected is that the recombinant protein behind the purifying causes the provide protection of SH-SY5Y neural cell injury for oxidative stress.Among the figure, 1: the cell survival rate of representing normal SH-SY5Y neurocyte; 2: represent the oxygenant modeling to handle the cell survival rate of back model group; 3: represent the cell survival rate after the recombinant protein (5nM) of high density is handled back oxidizer modeling; 4: represent the cell survival rate after the recombinant protein (0.5nM) of lower concentration is handled back oxidizer modeling.
Fig. 7: reorganization Trx-TAT-hMsrA fusion rotein causes the provide protection of neural cell injury behind the purifying for parkinsonism related pathologies factor MPP; Fig. 7 reflection be the provide protection of the cell injury that the recombinant protein behind the purifying causes for MPP.Among the figure, 1: the cell survival rate of representing normal SH-SY5Y neurocyte; 2: represent MPP to handle the cell survival rate of back model group; 3: add the cell survival rate after the MPP modeling after representing the recombinant protein (5nM) of high density to handle; 4: add the cell survival rate after the MPP modeling after representing the recombinant protein (0.5nM) of lower concentration to handle.
Fig. 8: reorganization Trx-TAT-hMsrA fusion rotein causes the provide protection of cell calcium overload behind the purifying for oxidation; What Fig. 8 reflected is the provide protection that the Chinese hamster ovary celI calcium ion that the recombinant protein behind the purifying causes for oxidation overloads.Among the figure, 1: represent oxidation to cause the result of calcium ion overload on the normal Chinese hamster ovary celI; 2: represent recombinant protein (5nM) to handle the result that rear oxidation causes calcium ion overload on the normal Chinese hamster ovary celI.340/380 Ratio value is represented free calcium ion concentration in the born of the same parents.
Embodiment
Embodiment 1 preparation fusion rotein of the present invention
1. the structure of reorganization Trx-TAT-hMsrA fusion protein expression vector
The carrier collection of illustrative plates that makes up is seen accompanying drawing 1.
The detailed step of vector construction:
(1). order-checking: the Pcmv-XL4 carrier (Beijing YiXin Industry Science and Technology Ltd.) that contains the hMsrA gene; Giving Beijing AudioCodes biotechnology Ltd checks order; Humanized's in sequencing result and the gene pool MsrA gene is consistent, shows that this plasmid can use.
(2). design primer: in order to extract the hMsrA gene from the Pcmv-XL4 carrier; Changing to the pet32a carrier gets on; With BamHI and XhoI is restriction enzyme site; Design a pair of primer, and on designed primer, add the Tat sequence, 5 ' terminal sequence: 5-CGCGGATCCGGTTACGGTCGTAAGAAACGTAGACAGCGCAGACGTGGTCGCCCT CCCATGCTCTCGGC-3;
3 ' terminal sequence:
5-CCGCTCGAGTTATTTTTTAATACCCACTGGGCAGGACACGC-3,
It is synthetic to give Shanghai Sangon Biological Engineering Technology And Service Co., Ltd.
(3) .PCR: after primer is sent here, owing to be pulverous, volatilization easily, the centrifugal 13000rpm of elder generation, 1min lets primer deposit, and adds the ddH2O of sterilization by the method that provides on the synthetic report.Use the PCR instrument of Bio-Rad to increase, the PCR system comprises 7 kinds: { template: 0.6ul, 0.37ug/ul; Primer up:0.5ul; Primer down:0.5ul; Pfu:1ul; DNTP:4ul; Pfu buffer:5ul; H2O:38.4ul}.The program setting of PCR: { initial sex change: 3min, 95 ℃; Sex change: 30s, 94 ℃; Annealing: 30s, 54 ℃; Extend: 1min, 72 ℃; Circulation: 29 times; The final extension: 10min, 72 ℃; At last: 8 ℃, forever}.PCR carries out electrophoresis after finishing, and identifies whether PCR is successful: { first swimming lane: DNA ladder; Second swimming lane: PCR sample.Electrophoretic program setting: 100V, 35min, after electrophoresis finished, with gel imaging appearance observations, seeing did not have very bright purpose band, the correct position of purpose band carries out next step }.
(4) the .PCR product reclaims: cut with a knife correct purpose band get off, reclaim test kit specification sheets (sky, Beijing root biochemical technology ltd) by gel and carry out the gel recovery.
(5). enzyme is cut: enzyme is cut and is comprised that purpose fragment Tat-MsrA enzyme is cut with carrier pet32a enzyme and cut.The purpose fragment enzyme system of cutting comprises: { purpose fragment (50ul): 36ul, 0.25ug/ul; BamHI:0.5ul; XHOI:0.5ul; BSA:0.5ul; NEbufferIII:5ul; H2O:7.5ul}.The carrier enzyme system of cutting comprises: { carrier: 15ul, 0.37ug/ul; BamHI:0.5ul; XHOI:0.5ul; XHOI:0.5ul; BSA:0.5ul; NEbufferIII:5ul; H2O:35.5ul}.The enzyme tangent condition is 37 ℃, 12h.
(6). the enzyme switchback is received: the purpose fragment is PCR and is reclaimed, and carrier is done gel and reclaimed, and recovery method is undertaken by test kit specification sheets (sky, Beijing root biochemical technology ltd).
(7). connect: { linked system comprises: carrier: 4ul; Goal gene: 3ul; T4 ligase enzyme: 1ul; T4buffer:1ul; H2O:1ul} placed 7 hours for 16 ℃; Placed 9 hours for 4 ℃.
(8). transform: take out from-70 ℃ of refrigerators and experience peptide trans 5 α (the triumphant victory in Wuhan is biological), seal heat, make it to thaw rapidly with hand; Approximately 10min draws the adding of 10ul connection plasmid with liquid-transfering gun and experiences peptide, flicks mixing with finger; Put 4 ℃ of about 30min of refrigerator, taking-up contains Amp +The 2YT culture plate, be coated on the plank experiencing peptide, on super clean bench, operate, put into 37 ℃ incubator 14h.
(9). shake bacterium: 12 reasonable bacterium colonies of rising trend of picking are in the pipe of 12 15ml in the culture plate to clamp the lancet head with tweezers, and every pipe has had adding of the 3-4ml liquid nutrient medium of Amp+ at 37 ℃, shook in the shaking table of 280rpm 14 hours.
(10). plasmid extracts in a small amount: the operation instructions of extracting test kit by plasmid is in a small amount operated, and runs agarose gel electrophoresis behind the extraction plasmid, and deposition condition is: 108V, 55min, whether the preliminary evaluation goal gene connects up.
(11). enzyme is cut evaluation: the enzyme of doing of choosing 3 band correct positions in the electrophoresis result of extracting in a small amount from plasmid is cut evaluation, and 37 ℃, the 3h enzyme is cut; Electrophoresis then; Observe whether the purpose band is arranged,, show that connection maybe success if the purpose band of size, correct position is arranged.
(12). order-checking: cut the correct order-checking of picking in the result of evaluation from enzyme, forward uses sequencing primer T7, oppositely uses T7ter, and sequencing result comes out, use software DNAssist to carry out sequence assembly after, sequence is correct, the molecule construction success.The nucleotide sequence of coding reorganization Trx-Tat-hMsrA fusion rotein is shown in SEQ ID NO:2.
2. reorganization integration and the abduction delivering of Trx-TAT-hMsrA antigen-4 fusion protein gene in the BL21 expression strain
With containing the proteic recombinant plasmid transformed e. coli bl21 of Trx-TAT-hMsrA (Wuhan life technology ltd) expression strain, coating contains the LB agar plate of penbritin, and 37 ℃ of constant temperature culture are spent the night, and grow better bacterium colony on the flat board.The positive bacterium colony of picking is seeded in the LB test tube that 10ml contains amicillin resistance, and 37 ℃, 280rmin, thermal agitation overnight cultures.Spend the night in 1: 100 ratio inoculation next day, and culture contains in the LB test tube of penbritin (containing whole mass concentration is 50mgL) resistance in 200mL, and being cultured to OD600nm in 37 ℃ of thermal agitations is 0.6-0.8; Dividing equally this culture is two portions; A part add isopropyl ss thiogalactoside (IPTG) to final concentration be 1mmolL with abduction delivering, another part does not add IPTG and compares, and continues to cultivate 4h; 4 ℃, 12000rmin.Centrifugal 15min results thalline, 1L add the resuspended thalline of 50mL binding buffer liquid (20mmol/LTris.HCl, pH 7.9 for 5mmol/L imidazoles, 500mmol/LNaCl), add PMSF, carrying out ultrasonic bacteria breaking (pulse:10s, 10s under the ice bath state then at 1: 1000; Amp:60%; Timer:16min), after the abundant fragmentation of UW, 4 ℃, behind the centrifugal 20min of 12000r/min, then fusion rotein is present in the supernatant with natural, soluble form.Decide protein concentration, collect and respectively to organize sample, by 4: 1 volumes (sample: sample-loading buffer) with the abundant mixing of 5 * sample-loading buffer after, heat inactivation 5min in the boiling water.Each sample of getting same protein amount (20 μ g) carries out the SDS-PAGE electrophoretic analysis.According to prescription in the table one, preparation SDS-polyacrylamide gel (SDS-PAGE).According to prescription in the table two, the preparation electrophoretic buffer.
Table one
Separation gel (10%) Concentrate glue (4%)
Ultrapure water (ml) 3.2 2.4
1.5M Tris(8.8)(ml) 2.7 0.615
30%Acry/bis(ml) 2 0.5
10%SDS(μl) 80 40
TEMED(μl) 80 40
10%APS(μl) 3.2 4
TV: 8(ml) 4(ml)
Table two
Reagent Concentration Configuration (500ml)
Tris-base 25mM(pH8.3)
Glycocoll 200mM
SDS 0.1%
Ultrapure water Be settled to 500ml after the dissolving
Every swimming lane adds equal protein (general about 20 μ g), and 100V voltage is through SDS-polyacrylamide gel (SDS-PAGE) electrophoretic separation 120min.After electrophoresis finishes; Behind coomassie brilliant blue R250 dyeing 40min; With the destainer that contains 10% Glacial acetic acid min. 99.5 and 10% methyl alcohol decolour to background colourless till, through albumen marker contrast, and do not add the contrast of IPTG inductive and compare; Discovery has a large amount of Trx-TAT-hMsrA expressing fusion proteins near 45KD.Referring to accompanying drawing 2.
3. the purifying of reorganization Trx-TAT-hMsrA fusion rotein
Supernatant changed over to Ni is housed 2+In the chromatography column of-NTA resin (qiagen company), after finishing, last appearance leaves standstill 2h, so that Ni in the label of 6 Histidines and the filler 2+Fully combine, collect.Ni-NTA fast startkit specification sheets in strict accordance with QIAGEN company adds wash buffer, collects.Add Elute buffer, collect.Marked; The capable SDS-PAGE electrophoresis of all collection liquid (method is with embodiment 2); After electrophoresis finishes, behind coomassie brilliant blue R250 dyeing 40min, with the destainer that contains 10% Glacial acetic acid min. 99.5 and 10% methyl alcohol decolour to background colourless till; Through albumen marker contrast, can draw the relative molecular mass of target protein.The result is referring to accompanying drawing 3.It is thus clear that obviously eliminated nearly all foreign protein behind the purifying.Carry out centrifugally concentrating that (2000rpm, 15min), after the filter membrane degerming of the fusion rotein of purifying with 0.22 μ m ,-20 ℃ of preservations are subsequent use with the albumen evaporating pipe of Millipore.
It below is the aminoacid sequence table that the present invention relates to.
The sequence signature of SEQ ID NO:1:
(A) length: 416 amino acid
(B) type: amino acid
(C) chain: strand
(D) topology: linearity
The sequence signature of SEQ ID NO:2:
(A) length: 1248 bases
(B) type: nucleic acid
(C) chain: strand
(D) topology: linearity
Sequence table
< 110>Central China University of Science and Technology
< 120>reorganization Trx-TAT-hMsrA fusion rotein and the application aspect neurocyte protection thereof
<140> 201010197729.4
<141> 2010-06-11
<160> 4
<170> PatentIn version 3.5
<210> 1
<211> 416
<212> PRT
< 213>manual work
<400> 1
Met Ser Asp Lys Ile Ile His Leu Thr Asp Asp Ser Phe Asp Thr Asp
1 5 10 15
Val Leu Lys Ala Asp Gly Ala Ile Leu Val Asp Phe Trp Ala Glu Trp
20 25 30
Cys Gly Pro Cys Lys Met Ile Ala Pro Ile Leu Asp Glu Ile Ala Asp
35 40 45
Glu Tyr Gln Gly Lys Leu Thr Val Ala Lys Leu Asn Ile Asp Gln Asn
50 55 60
Pro Gly Thr Ala Pro Lys Tyr Gly Ile Arg Gly Ile Pro Thr Leu Leu
65 70 75 80
Leu Phe Lys Asn Gly Glu Val Ala Ala Thr Lys Val Gly Ala Leu Ser
85 90 95
Lys Gly Gln Leu Lys Glu Phe Leu Asp Ala Asn Leu Ala Gly Ser Gly
100 105 110
Ser Gly His Met His His His His His His Ser Ser Gly Leu Val Pro
115 120 125
Arg Gly Ser Gly Met Lys Glu Thr Ala Ala Ala Lys Phe Glu Arg Gln
130 135 140
His Met Asp Ser Pro Asp Leu Gly Thr Asp Asp Asp Asp Lys Ala Met
145 150 155 160
Ala Asp Ile Gly Ser Gly Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg
165 170 175
Arg Gly Arg Pro Pro Met Leu Ser Ala Thr Arg Arg Ala Cys Gln Leu
180 185 190
Leu Leu Leu His Ser Leu Phe Pro Val Pro Arg Met Gly Asn Ser Ala
195 200 205
Ser Asn Ile Val Ser Pro Gln Glu Ala Leu Pro Gly Arg Lys Glu Gln
210 215 220
Thr Pro Val Ala Ala Lys His His Val Asn Gly Asn Arg Thr Val Glu
225 230 235 240
Pro Phe Pro Glu Gly Thr Gln Met Ala Val Phe Gly Met Gly Cys Phe
245 250 255
Trp Gly Ala Glu Arg Lys Phe Trp Val Leu Lys Gly Val Tyr Ser Thr
260 265 270
Gln Val Gly Phe Ala Gly Gly Tyr Thr Ser Asn Pro Thr Tyr Lys Glu
275 280 285
Val Cys Ser Glu Lys Thr Gly His Ala Glu Val Val Arg Val Val Tyr
290 295 300
Gln Pro Glu His Met Ser Phe Glu Glu Leu Leu Lys Val Phe Trp Glu
305 310 315 320
Asn His Asp Pro Thr Gln Gly Met Arg Gln Gly Asn Asp His Gly Thr
325 330 335
Gln Tyr Arg Ser Ala Ile Tyr Pro Thr Ser Ala Lys Gln Met Glu Ala
340 345 350
Ala Leu Ser Ser Lys Glu Asn Tyr Gln Lys Val Leu Ser Glu His Gly
355 360 365
Phe Gly Pro Ile Thr Thr Asp Ile Arg Glu Gly Gln Thr Phe Tyr Tyr
370 375 380
Ala Glu Asp Tyr His Gln Gln Tyr Leu Ser Lys Asn Pro Asn Gly Tyr
385 390 395 400
Cys Gly Leu Gly Gly Thr Gly Val Ser Cys Pro Val Gly Ile Lys Lys
405 410 415
<210> 2
<211> 1248
<212> DNA
< 213>manual work
<400> 2
atgagcgata aaattattca cctgactgac gacagttttg acacggatgt actcaaagcg 60
gacggggcga tcctcgtcga tttctgggca gagtggtgcg gtccgtgcaa aatgatcgcc 120
ccgattctgg atgaaatcgc tgacgaatat cagggcaaac tgaccgttgc aaaactgaac 180
atcgatcaaa accctggcac tgcgccgaaa tatggcatcc gtggtatccc gactctgctg 240
ctgttcaaaa acggtgaagt ggcggcaacc aaagtgggtg cactgtctaa aggtcagttg 300
aaagagttcc tcgacgctaa cctggccggt tctggttctg gccatatgca ccatcatcat 360
catcattctt ctggtctggt gccacgcggt tctggtatga aagaaaccgc tgctgctaaa 420
ttcgaacgcc agcacatgga cagcccagat ctgggtaccg acgacgacga caaggccatg 480
gctgatatcg gatccggtta cggtcgtaag aaacgtagac agcgcagacg tggtcgccct 540
cccatgctct cggccacccg gagggcttgc cagctcctcc tcctccacag cctctttccc 600
gtcccgagga tgggcaactc ggcctcgaac atcgtcagcc cccaggaggc cttgccgggc 660
cggaaggaac agacccctgt agcggccaaa catcatgtca atggcaacag aacagtcgaa 720
cctttcccag agggaacaca gatggctgta tttggaatgg gatgtttctg gggagctgaa 780
aggaaattct gggtcttgaa aggagtgtat tcaactcaag ttggttttgc aggaggctat 840
acttcaaatc ctacttataa agaagtctgc tcagaaaaaa ctggccatgc agaagtcgtc 900
cgagtggtgt accagccaga acacatgagt tttgaggaac tgctcaaggt cttctgggag 960
aatcacgacc cgacccaagg tatgcgccag gggaacgacc atggcactca gtaccgctcg 1020
gccatctacc cgacctctgc caagcaaatg gaggcagccc tgagctccaa agagaactac 1080
caaaaggttc tttcagagca cggcttcggc cccatcacta ccgacatccg ggagggacag 1140
actttctact atgcggaaga ctaccaccag cagtacctga gcaagaaccc caatggctac 1200
tgcggccttg ggggcaccgg cgtgtcctgc ccagtgggta ttaaaaaa 1248
<210> 3
<211> 68
<212> DNA
< 213>manual work
<400> 3
cgcggatccg gttacggtcg taagaaacgt agacagcgca gacgtggtcg ccctcccatg 60
ctctcggc 68
<210> 4
<211> 41
<212> DNA
< 213>manual work
<400> 4
ccgctcgagt tattttttaa tacccactgg gcaggacacg c 41

Claims (3)

1. reorganization Trx-Tat-hMsrA fusion rotein is characterized in that: sequence as SEQ ID NO:1Shown in.
2. the nucleotide sequence of the described reorganization of coding claim 1 Trx-Tat-hMsrA fusion rotein is characterized in that: sequence as SEQ ID NO:2Shown in.
3. the application of the described reorganization of claim 1 Trx-Tat-hMsrA fusion rotein in the medicine of preparation control oxidative stress damage.
CN2010101977294A 2010-06-11 2010-06-11 Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection Expired - Fee Related CN101974089B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010101977294A CN101974089B (en) 2010-06-11 2010-06-11 Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010101977294A CN101974089B (en) 2010-06-11 2010-06-11 Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection

Publications (2)

Publication Number Publication Date
CN101974089A CN101974089A (en) 2011-02-16
CN101974089B true CN101974089B (en) 2012-09-26

Family

ID=43574005

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010101977294A Expired - Fee Related CN101974089B (en) 2010-06-11 2010-06-11 Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection

Country Status (1)

Country Link
CN (1) CN101974089B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103160487A (en) * 2011-12-15 2013-06-19 曹林 Heparinase I fusion protein
CN104479027B (en) * 2014-11-20 2017-06-16 华中科技大学 A kind of medicine for preventing and treating senile dementia
CN105238798B (en) * 2015-11-18 2018-11-13 武汉华肽生物科技有限公司 People source methionine sulfoxide reductase A expressing genes, carrier, bacterial strain and method
WO2017123440A1 (en) * 2016-01-15 2017-07-20 Pierce Biotechnology, Inc. Protein preparation by reduction of oxidized methionines
CN110179689A (en) * 2019-05-23 2019-08-30 武汉华肽生物科技有限公司 A kind of liniment based on gene recombinant protein Ta-hMsrA
CN110606895A (en) * 2019-08-26 2019-12-24 武汉大学 Structure and construction method of human recombinant methionine sulfoxide reductase A protein
CN110787284A (en) * 2019-11-23 2020-02-14 胡书群 Mixed small peptide TAT-SHC for treating ischemic brain injury and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1246534A (en) * 1998-08-31 2000-03-08 上海新黄浦复旦基因工程有限公司 Coding sequence of human methionine sulfoxide reductase, its encoded polypeptide and its preparing process
CN1563386A (en) * 2004-03-18 2005-01-12 上海交通大学 Reducing enzyme protein coded sequence of sulfoxide methionine of cotton
CN1626658A (en) * 2003-12-12 2005-06-15 国家小麦工程技术研究中心 Gene in thioredoxin class blue 'black india paspalum' in application of producing malting barley

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1246534A (en) * 1998-08-31 2000-03-08 上海新黄浦复旦基因工程有限公司 Coding sequence of human methionine sulfoxide reductase, its encoded polypeptide and its preparing process
CN1626658A (en) * 2003-12-12 2005-06-15 国家小麦工程技术研究中心 Gene in thioredoxin class blue 'black india paspalum' in application of producing malting barley
CN1563386A (en) * 2004-03-18 2005-01-12 上海交通大学 Reducing enzyme protein coded sequence of sulfoxide methionine of cotton

Also Published As

Publication number Publication date
CN101974089A (en) 2011-02-16

Similar Documents

Publication Publication Date Title
CN101974089B (en) Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection
CN109593126B (en) Polypeptide, its production method and purposes
del Mar Yust et al. Rapeseed protein hydrolysates: a source of HIV protease peptide inhibitors
Sivanesan et al. Quantitative analysis of VirB8− VirB9− VirB10 interactions provides a dynamic model of type IV secretion system core complex assembly
York et al. Distinct requirements for signal peptidase processing and function in the stable signal peptide subunit of the Junin virus envelope glycoprotein
CN104215775B (en) The beta-lactam antibiotic receptor method detection kit preparation method of PBP PBP6 and detection method
CN107438670A (en) Chimeric polyeptides
CN102757974B (en) Novel preparation method for recombinant human epidermal growth factor
CN110117323A (en) A kind of solubility source of people keratin and its application
CN107884578A (en) For echinococcosis antibody test card in Quantitative detection serum
Molloy et al. Characterisation of the major extracellular proteases of Stenotrophomonas maltophilia and their effects on pulmonary antiproteases
CN107446034A (en) One group of fluorescin probe and its preparation method and application
CN105368806B (en) A kind of Fixedpoint mutation modified yeast dipeptidyl peptidase II I
Newton et al. Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth
Volokhina et al. Species-specificity of the BamA component of the bacterial outer membrane protein-assembly machinery
Kovács et al. Characterization of the proprotein convertase-mediated processing of peroxidasin and peroxidasin-like protein
Singkhamanan et al. Amino acid residues in the N-terminal region of the BinB subunit of Lysinibacillus sphaericus binary toxin play a critical role during receptor binding and membrane insertion
Sakai et al. Soritesidine, a Novel Proteinous Toxin from the Okinawan Marine Sponge Spongosorites sp.
CN106243199B (en) There is the Vip3Aa11 protein mutant of high activity to beet armyworm
Raut et al. Isolation and characterization of protease producing bacteria from upper respiratory tract of wild chicken
CN108893476A (en) Babesiamicrofti 2D97 antigen protein and its application
Jeong et al. The adherence-associated Fdp fasciclin I domain protein of the biohydrogen producer Rhodobacter sphaeroides is regulated by the global Prr pathway
CN106554945B (en) A kind of fructosyl peptide oxidase that thermal stability is high and its encoding gene and purposes
Folsom et al. Proteomic Analysis of a Hypochlorous Acid–Tolerant Listeria monocytogenes Cultural Variant Exhibiting Enhanced Biofilm Production
Sousa et al. Antagonistic activity expressed by Shigella sonnei: identification of a putative new bacteriocin

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20110216

Assignee: Wuhan Hua Peptide Biological Technology Co., Ltd.

Assignor: Huazhong University of Science and Technology

Contract record no.: 2014420000115

Denomination of invention: Recombination fusion protein Trx-TAT-hMsrA and application thereof to aspect of nerve cell protection

Granted publication date: 20120926

License type: Exclusive License

Record date: 20140619

LICC Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120926

Termination date: 20210611